Literature DB >> 29212074

Late-Onset Alopecia Areata: A Retrospective Cohort Study.

Anna Lyakhovitsky1, Sarit Gilboa, Anna Eshkol, Aviv Barzilai, Sharon Baum.   

Abstract

BACKGROUND: Alopecia areata is an immune-mediated disease presenting with sudden onset of nonscarring hair loss. Onset is more common earlier in life, and little is known regarding late-onset alopecia areata.
OBJECTIVES: To describe the epidemiology, clinical patterns, disease course, and outcome of late-onset alopecia areata in Israeli patients referred to a tertiary medical center.
MATERIALS AND METHODS: This retrospective cohort study considered patients whose disease onset occurred at age ≥50 years. Patients were recruited from among all alopecia areata patients visiting a tertiary center between January 2009 and April 2015.
RESULTS: Of the 29 people included, 25 (86.2%) were female (female-to-male ratio, 6.2:1). There was a family history of alopecia areata in 17.2%, thyroid disease in 31%, atopic background in 6.9%, and 17/29 (58.6%) reported a significant stressful event. The most common disease pattern was patchy, and disease was mild in the majority of participants. Complete hair regrowth was observed in 82.8% of participants, and 37.9% relapsed.
CONCLUSION: Late-onset alopecia areata is characterized by marked female predominance, less extensive disease, and a high incidence of complete hair regrowth.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Age of onset; Alopecia; Alopecia areata; Hair disorders; Late onset

Mesh:

Year:  2017        PMID: 29212074     DOI: 10.1159/000481881

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  2 in total

1.  The Immunological Association between Alopecia Areata and Respiratory Diseases: A Systematic Review.

Authors:  Calvin T Sung; Franchesca D Choi; Margit Juhász; Natasha Atanaskova Mesinkovska
Journal:  Skin Appendage Disord       Date:  2019-02-26

2.  Comorbidities of Alopecia Areata in Finland between 1987 and 2016.

Authors:  Idamaria Laitinen; Jari Jokelainen; Kaisa Tasanen; Laura Huilaja
Journal:  Acta Derm Venereol       Date:  2020-02-25       Impact factor: 3.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.